Regulations.gov document
2025-000277 - Europharma Inc. - Berberine MetX Enhanced Absorption - Supports overall…
Other · FDA-2025-S-0024 · posted Apr 21, 2025
Key facts
| Document ID | FDA-2025-S-0024-0198 |
|---|---|
| Title | 2025-000277 - Europharma Inc. - Berberine MetX Enhanced Absorption - Supports overall metabolic health, blood sugar levels, and cholesterol levels |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2025-S-0024 |
| Posted | Apr 21, 2025 |
| Comment period opens | Apr 21, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: